6 July 2006

Panel Discussion: Nanotechnology Safety and Environmental Issues – Deborah Willcocks, International Conference on Nanotechnology and Nanoscience, Brisbane QLD

17 & 18 July 2006

Nanomaterials: Technical Issues and Role of OECD – Deborah Willcocks, Nanotechnology International Workshop on Regulatory Challenges, Melbourne VIC

7 October 2006

The Make-Up of Cosmetic Regulations: The Role of the Pharmacist – Roshini Jayewardene, 12^th Pharmacy Australia Congress, Cairns QLD

24 October 2006

Triclosan: the potential for bioaccumulation, to cause harm to breast-fed babies and methodology for risk characterization – Sneha Satya; Beryllium and beryllium compounds – Helen Ritchie, Advisory Group on Chemical Safety, Canberra ACT

31 October – 1 November 2006

NICNAS and the Laboratory – Bob Graf, Laboratory Managers Conference 2006, Science Industry Australia, Melbourne VIC

10 November 2006

Overview of Nanomaterials: Regulatory Activities – Deborah Willcocks, ACCORD industry meeting, Sydney NSW

11 December 2006

NICNAS Overview of Nanomaterials, International Activities on Nanomaterials – Deborah Willcocks, National Health and Medical Research Council Nanotechnology Roundtable, Canberra ACT

6 February 2007

Outcomes of the International Workshop on Skin Sensitisation in Chemical Risk Assessment – Paul Harvey; PentaBDE Hazard Classification and LOAEL Identification – Kerry Nugent, Advisory Group on Chemical Safety, Canberra ACT

27 February 2007
Current NICNAS Reform Activities – Bob Graf, PACIA NSW Regulatory Affairs seminar, Sydney NSW

2 March 2007

Lead Compounds in Industrial Surface Coatings and Inks International – Stephen Zaluzny, International Paint and Inks Conference, Sydney NSW

10 May 2007
NICNAS Review of Existing Chemicals Program – Bob Graf, with Liz Hanna, CEF, HAZMAT 2007, Sydney NSW

23 May 2007

Cosmetic Regulation in Australia – Hana Hamdan, Australian Society of Cosmetic Chemists Meeting, Sydney NSW

24 May 2007

NICNAS: New directions and perspectives – Marian Healy, ACCORD Briefing and AGM, Melbourne VIC

5 June 2007

Decabromodiphenyl ether (decaBDE): Hazard assessment – Carcinogenicity study interpretation – Kerry Nugent, Advisory Group on Chemical Safety, Canberra ACT